Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Disposal

21 Jul 2009 07:00

RNS Number : 9867V
St Helen's Capital PLC
21 July 2009
 

PRIVATE & CONFIDENTIAL

St Helen's Capital Plc

("St Helen's Capital" or the "Company")

 

Proposed Disposal of Business and Directorate Change

 

St Helen's Capital announces that on 20 July 2009 it signed heads of agreement relating to the proposed sale, subject to contract, of its business and associated assets (the "Disposal")  to Whim Gully Capital LLP ("WGC"), which is an FSA authorised firm and a PLUS corporate adviser and broker, for a cash consideration of £250,000. 

WGC is owned by Edward Vandyk, his wife, Oliver Vaughan and Oliver Cooke Edward Vandyk and Oliver Vaughan are directors of Evolve Capital plc ("Evolve") and its 57% owned subsidiary Astaire Group plc ("Astaire"). WGC has entered into heads of agreement with Evolve ("WGC Heads") whereby Evolve will have a period of exclusivity to acquire WGC, conditional on and including the benefit of any contract WGC enters into with St Helen's Capital. No specific terms in relation to the proposed acquisition of WGC by Evolve are contained in the WGC Heads and such terms, if agreed, will be determined by the independent directors of Evolve in conjunction with Evolve's advisers and will constitute a related party transaction under the AIM Rules for Companies. It is also probable that if the proposed acquisition of WGC proceeds it will require the approval of Evolve's shareholders pursuant to section 190 of the Companies Act 2006 in which case, circular containing further information about the proposed acquisition of WGC and convening a General Meeting of Evolve to approve the proposed acquisition will be sent to Evolve's shareholders.

It is envisaged that Evolve may thus acquire an enlarged PLUS advisory business which, when the St Helen's Capital and WGC existing PLUS quoted clients are combined, will have over 25 PLUS quoted clients and be a significant participant in the PLUS quoted market. It is envisaged that the PLUS advisory business acquired would trade under the St Helen's name. At the time of its flotation on AIM in December 2007 Evolve stated its intention to focus on the PLUS quoted market and which it has continued to pursue since its reverse takeover of Astaire in December 2008

The St Helen's Capital heads of agreement provide that the Disposal is subject, inter alia, to completion by WGC of its due diligence exercise and the execution of a definitive sale and purchase agreement ("Sale Agreement"). The heads of agreement provide a period of 3 months' exclusivity to WGC.

The Disposal will result in a fundamental change to the business of St Helen's Capital and would therefore be subject to the approval of the Company's shareholders. Accordingly, as soon as reasonably practicable following the signing of the Sale Agreement, a circular containing further information about the Disposal and convening a General Meeting of the Company to approve the Disposal will be sent to shareholders. If the Disposal is approved at the General Meeting, St Helen's Capital intends to continue to be traded on AIM and will be treated as an investment company.

St Helen's Capital also announces that, with effect from 20 July 2009, Barry Hocken, head of the Company's PLUS Market Division, has resigned as a Director of the Company to pursue other business interests overseas. Barry has agreed to act as a Consultant to St Helen's Capital for a period of at least 6 months following his resignation. Mark Anwyl will take over as head of the Company's PLUS Markets Division. 

The Directors of St Helen's Capital would like to thank to Barry for his immense contribution to the development of the Company's PLUS Markets Division and to wish him well for the future. 

Enquiries:

St Helen's Capital Plc 020 7628 5582

Mark Warde-Norbury

 

Strand Partners Limited (Nominated Adviser to St Helen's Capital Plc) 020 7409 3490

James Harris

 

St Brides Media & Finance Ltd (Financial PR to St Helen's Capital Plc) 020 7236 1177

Susie Callear

 

Whim Gully Capital LLP / Evolve Capital PLC 020 7448 4400

Edward Vandyk

 

Fairfax I.S. PLC (Nominated Adviser to Evolve Capital PLC)

Adam Hart and Jeremy Porter 020 7598 5368

 

Maitland (Financial PR to Evolve Capital PLC)

Neil Bennett and George Hudson 020 7379 5151

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISDBGDRRBDGGCG
Date   Source Headline
2nd Oct 20207:00 amRNSChange of Adviser
28th Sep 20201:20 pmRNSPosting of Annual Report and Notice of AGM
25th Aug 202010:39 amRNSHolding(s) in Company
24th Aug 20207:00 amRNSFinal Results
10th Aug 202010:03 amRNSHolding(s) in Company
7th Aug 20201:05 pmRNSHolding(s) in Company
6th Aug 202010:09 amRNSHolding(s) in Company
5th Aug 202011:35 amRNSHolding(s) in Company
4th Aug 20201:03 pmRNSHolding(s) in Company
30th Jul 20204:40 pmRNSSecond Price Monitoring Extn
30th Jul 20204:35 pmRNSPrice Monitoring Extension
17th Jan 20203:31 pmRNSHolding(s) in Company
12th Dec 20193:08 pmRNSHalf-year Report
24th Sep 201912:16 pmRNSHolding(s) in Company
23rd Sep 20193:38 pmRNSResult of AGM
2nd Sep 20192:46 pmRNSPosting of Annual Report and Notice of AGM
29th Aug 20193:48 pmRNSFinal Results
12th Jul 20191:45 pmRNSBoard Change
1st May 201912:39 pmRNSTrading Statement
25th Jan 201910:16 amRNSInterim Results
12th Dec 20187:00 amRNSChange of Adviser
28th Nov 20185:18 pmRNSChange of Adviser
8th Nov 20183:16 pmRNSDirector/PDMR Shareholding
4th Oct 20182:11 pmRNSResult of AGM
13th Sep 20189:50 amRNSPosting of Annual Report and Notice of AGM
21st Aug 20186:13 pmRNSHolding(s) in Company
21st Aug 201811:35 amRNSFinal Results
5th Jul 20181:55 pmRNSHolding(s) in Company
16th Apr 20182:04 pmRNSHolding(s) in Company
7th Mar 20182:19 pmRNSDirector/PDMR Shareholding
29th Jan 20187:00 amRNSInterim Results
25th Jan 20182:25 pmRNSHolding(s) in Company
8th Dec 201712:01 pmRNSHolding(s) in Company
9th Nov 20175:01 pmRNSTrading Update
14th Sep 201710:57 amRNSResult of AGM
18th Aug 20173:59 pmRNSPosting of Annual Report and Notice of AGM
14th Aug 201712:20 pmRNSDirector/PDMR Shareholding
27th Jul 20177:00 amRNSFinal Results
25th Jan 20171:50 pmRNSCapital reduction update
22nd Dec 201611:37 amRNSDirector/PDMR Shareholding
16th Dec 20167:00 amRNSHalf-year Report
15th Sep 20161:13 pmRNSDirector/PDMR Shareholding
14th Sep 201612:54 pmRNSResult of AGM
24th Aug 20164:36 pmRNSPosting of Annual Report & Notice of AGM
25th Jul 20167:00 amRNSFinal Results
4th May 201611:42 amRNSStmnt re Share Price Movement
20th Jan 20163:14 pmRNSDirectorate Change
19th Jan 20161:11 pmRNSStmnt re Share Price Movement
17th Dec 20157:00 amRNSHalf Yearly Report
19th Nov 20155:30 pmRNSNorthfield UK Solar Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.